PureVax Feline 4/Rabies (Canada)

Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci-Rabies Vaccine

Modified Live Virus and Chlamydia, Canarypox Vector

(RCCP/rRabies-SWD)

DESCRIPTION: PUREVAX^® Feline 4/Rabies contains a nonadjuvanted lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci; recombinant vectored rabies vaccine; plus a sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to rabies. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge studies in susceptible cats.

INDICATIONS: PUREVAX^® Feline 4/Rabies is recommended for the vaccination of healthy cats 8 weeks of age and older for prevention of disease due to feline rhinotracheitis, calici, panleukopenia, and rabies viruses and as an aid in the reduction of disease due to Chlamydia psittaci.

DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously into healthy cats. For primary vaccination of cats younger than 12 weeks of age, revaccinate every 3 to 4 weeks with the last dose given at or over 12 weeks of age. For primary vaccination of cats 12 weeks or older, revaccinate with a second 1 ml dose of this product or Purevax^® Feline 4, 3 to 4 weeks later. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Use entire contents immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn this container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate pregnant cats. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.

SOLD TO VETERINARIANS ONLY.

Store at 2-7°C (35-45°F).

For Veterinary Use Only.

PUREVAX is a registered trademark of MERIAL.

Manufactured By MERIAL INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, (Québec), H9X 4B6, Canada

CPN: 11820533